Surgery News and Research

RSS

DePuy Synthes Trauma announces launch of new Radial Head Prosthesis System

DePuy Synthes Trauma announces that it is launching the new Radial Head Prosthesis System for primary and revision joint replacement of the radial head to restore joint function. The System offers several benefits over current technologies.

16 Dec 2013

New technologies unveiled to provide expert care and streamline the process of treating breast cancer

Breast cancer patients are moms, wives, and caretakers. They are teachers, nurses, physicians and heads of industry. Today, more than ever before, women are delicately balancing the various roles of their lives. A breast cancer diagnosis and the treatment that follows is yet another challenge that unfortunately many women need to accommodate in their already busy schedules. That's why Jersey Shore University Medical Center, Ocean Medical Center and Riverview Medical Center offer technologies that provide expert care and streamline the process of treating breast cancer.

14 Dec 2013

UTHealth professor wins Founders' Laurel Award for exceptional service in the field of medical education

Arthur L. Day, M.D., professor of neurosurgery at The University of Texas Health Science Center at Houston and a neurosurgeon at the Mischer Neuroscience Institute at Memorial Hermann-Texas Medical Center, has received one of the top honors awarded by the Congress of Neurological Surgeons.

14 Dec 2013

Study reports increased risk of death in patients receiving anesthesia drug etomidate for surgery

Patients receiving the widely used anesthesia drug etomidate for surgery may be at increased risk or mortality and cardiovascular events, according to a study in the December issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

14 Dec 2013

Bisphosphonate zoledronate treatment not effective in women with chemoresistant breast cancer

Treatment with the bisphosphonate zoledronate did not improve outcomes for women with chemoresistant breast cancer, according to initial results of a phase III clinical trial presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.

14 Dec 2013

Researchers test promising new breast cancer drugs

The first investigator results from an unprecedented nationwide effort to test promising new breast cancer drugs before the tumor is removed were presented during the 2013 San Antonio Breast Cancer Symposium.

14 Dec 2013

UTHealth Medical School professor recognized for excellence in sarcoma treatment

Rex Marco, M.D., professor in the Department of Orthopaedic Surgery at The University of Texas Health Science Center at Houston Medical School, is the recipient of an award recognizing excellence in the treatment of a type of cancer called sarcoma.

14 Dec 2013

Clinical psychologist provides tips to survive holiday season without weight gain

Special family meals, holiday buffets and free drinks can be open invitations for disaster for the more than 50 percent of Americans who are struggling with their weight and dieting.

13 Dec 2013

Specialists use pioneering treatment to reduce high blood pressure in kidney patient

SPECIALISTS at Sheffield Teaching Hospitals NHS Foundation Trust have used a pioneering treatment to reduce high blood pressure in a kidney patient whose blood pressure could not be controlled with conventional medication.

13 Dec 2013

Arden Photonics BQM-50 Beam Propagation Analyser Compact offers easier way of characterizing laser beams

The Arden Photonics BQM-50 Beam Propagation Analyser Compact, based on a prototype developed by the National Physical Laboratory, offers customers a quicker and easier way of characterising laser beams to optimise their performance.

13 Dec 2013

NeuroPace- Responsive Neurostimulation System treatment to be offered at Spectrum Health

Spectrum Health will be the first health system in West Michigan and among the first in the nation to offer treatment with a newly FDA-approved device that uses electric stimulation of the brain for adult epilepsy patients whose seizures have not responded to medication.

13 Dec 2013

Genomic tests help in selecting the most effective therapy for breast cancer

Genomic tests that determine the molecular subtype of a woman's breast cancer provide a more precise prognosis and valuable guidance about the best treatment, according to new research led by Massimo Cristofanilli, M.D, Director of the Jefferson Breast Care Center at the Kimmel Cancer Center (KCC) and Thomas Jefferson University and Hospitals.

13 Dec 2013

Standardized research approaches needed for developing new treatments for neurofibromatosis

As potentially effective new treatments for neurofibromatosis (NF) are developed, standardized research approaches—including outcome measures specific to NF—are needed. The first report from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration has been published as a supplement to Neurology, the Official Journal of the American Academy of Neurology (AAN).

13 Dec 2013

Experts develop innovative technologies to improve healthcare and border security

With a solemn ceremony organized on December 11, 2013 NCBJ concluded the 85.5 million PLN worth "AiD" R&D project co-financed by European Union. Project outcomes include 3 demonstrators of innovative medical devices (Coline 6, IntraLine, and InLine PN50) and 2 demonstrators of cargo scanners developed to improve security at European border crossing checkpoints (SWAN and CANIS).

13 Dec 2013

Groundbreaking UVA research receives $3.3M NIH grant to increase lungs for transplantation

Groundbreaking research at the University of Virginia School of Medicine that aims to dramatically increase the number of lungs that can be used for transplant has received a $3.3 million grant from the National Institutes of Health.

13 Dec 2013

Breast cancer survivors taking AIs may experience reduction in joint pain on exercising

Breast cancer survivors taking aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane experienced a reduction in joint pain if they exercised while on treatment, according to results presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.

13 Dec 2013

Over-use of staging procedures more prevalent in younger, early-stage breast cancer patients

More than one third of younger, early stage breast cancer patients undergo unnecessary imaging procedures - including position emission tomography (PET), computed tomography (CT), nuclear medicine bone scans (NMBS) and tumor markers (TM) -- at the time of staging and diagnosis, according to research from The University of Texas MD Anderson Cancer Center.

13 Dec 2013

RPCI enrolls patients in clinical trials of immunotherapy approaches for treating genitourinary cancers

Researchers at the Roswell Park Cancer Institute Center for Immunotherapy are enrolling patients in three different clinical trials of novel immunotherapy approaches for treating genitourinary cancers.

13 Dec 2013

UCLA stem cell researchers track early development of human articular cartilage

Stem cell researchers from UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have published the first study to identify the origin cells and track the early development of human articular cartilage, providing what could be a new cell source and biological roadmap for therapies to repair cartilage defects and osteoarthritis. These revolutionary therapies could reach clinical trials within three years.

13 Dec 2013

New treatment needed for women with HER2- and hormone receptor-positive breast cancer with PIK3CA mutation

Women with breast cancer characterized by high levels of the protein HER2 and hormone receptors gained much less benefit from presurgery treatment with chemotherapy and HER2-targeted therapies if their cancer had one or more mutations in the PIK3CA gene, according to results presented here at the 2013 San Antonio Breast Cancer Symposium, held Dec. 10-14.

12 Dec 2013

Surgery News and Research

DePuy Synthes Trauma announces launch of new Radial Head Prosthesis System

New technologies unveiled to provide expert care and streamline the process of treating breast cancer

UTHealth professor wins Founders' Laurel Award for exceptional service in the field of medical education

Study reports increased risk of death in patients receiving anesthesia drug etomidate for surgery

Bisphosphonate zoledronate treatment not effective in women with chemoresistant breast cancer

Researchers test promising new breast cancer drugs

UTHealth Medical School professor recognized for excellence in sarcoma treatment

Clinical psychologist provides tips to survive holiday season without weight gain

Specialists use pioneering treatment to reduce high blood pressure in kidney patient

Arden Photonics BQM-50 Beam Propagation Analyser Compact offers easier way of characterizing laser beams

NeuroPace- Responsive Neurostimulation System treatment to be offered at Spectrum Health

Genomic tests help in selecting the most effective therapy for breast cancer

Standardized research approaches needed for developing new treatments for neurofibromatosis

Experts develop innovative technologies to improve healthcare and border security

Groundbreaking UVA research receives $3.3M NIH grant to increase lungs for transplantation

Breast cancer survivors taking AIs may experience reduction in joint pain on exercising

Over-use of staging procedures more prevalent in younger, early-stage breast cancer patients

RPCI enrolls patients in clinical trials of immunotherapy approaches for treating genitourinary cancers

UCLA stem cell researchers track early development of human articular cartilage

New treatment needed for women with HER2- and hormone receptor-positive breast cancer with PIK3CA mutation

Industry Focus eBook - Cell biology (5th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News